The global medical imaging market size was USD 47.25 billion in 2023, estimated at USD 49.61 billion in 2024 and is anticipated to reach around USD 80.52 billion by 2034, expanding at a CAGR of 4.96% from 2024 to 2034.
The global medical imaging market size accunted for USD 49.61 billion in 2024 and is predicted to reach around USD 80.52 billion by 2034, growing at a CAGR of 4.96% from 2024 to 2034.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. medical imaging market size was estimated at USD 13.56 billion in 2023 and is expected to be worth around USD 23.31 billion by 2034, at a CAGR of 5.04% from 2024 to 2034.
On the basis of geography, the North American market has dominated the segment as a result of its rapid technological advancement. The multiple facilities which are provided by the government to the people in order to maintain their health has helped the region to be a great opportunity for this market. The high prevalence of chronic diseases as a result of the huge geriatric population residing in this region, the demand for advanced imaging techniques has increased tremendously.
The Asia Pacific region also has shown a considerable growth as a result of the rapid development which is taking place in the healthcare sector. The European market is the next in line which has recorded a significant growth as a result of its rapid technological advancements.
The increasing number of patients suffering with chronic ailments and pathological disorders has boosted the demand for advanced medical imaging techniques. An increasing demand for detection tools which can perform early diagnosis of diseases has boosted the demand for advance medical imaging devices. With the improvement in the technology the reporting time which is required after the image has been scanned has also reduced considerably. The accuracy and precision of the imaging devices has also improved with the advancement in technology. The improvement in the government norms and policies regarding the reimbursement facilities provided to the patients has also boosted the market for medical imaging.
The rise in the numerous chronic diseases among the people as also helped the market to show a considerable growth during the forecast period. As the result of this repeated follow ups are required along with multiple imaging test which help to predict a prognosis for the case. This helps the medical expert to have a clear picture regarding the line of treatment to be followed and the possibilities of cure. Thus, the reliability of treatment increases and helps the patient to have faith in the health care sector. These imaging techniques include the X-Ray scan, CT scans and MRI scan. These respective imaging procedures are advised according to the requirement of the case. The pathological changes that have taken place in the body of the individual can be clearly observed with the help of the scans and images produced by the machine. A suitable line of treatment can be selected depending up on the disposable income of the patient. The high cost associated with the imaging procedures has hampered the growth of the market to a great extent. MRI scans prove to be the costliest among the group which is advised only if very essential. On the other hand, it provides the best study possible for any disease and helps to have the clearest picture available regarding the prognosis of the disease process. The increasing awareness among the people regarding the side effects of these imaging techniques has proved to be a challenge for the growth of the market. The number of side effects have been observed in the patients who have undergone multiple imaging procedures.
The occurrence of the pandemic had a negative as well as positive impact on the medical imaging market. The market suffered a negative impact as a result of the selective behavior of the hospital regarding the procedures performed in order to avoid cross infection to the patient as well as the medical staff. In order to reduce the risk of spread of diseases regular checkups and follow-ups were avoided by the hospitals and only covid cases were delt with. This reduces the number of cases for the imaging procedures which included the orthopedic patients. Orthopedic surgery is suffered the most due to this pandemic. CT scans and MRI of the other parts of the body were avoided in order to keep the machines available for the covid patients. Increasing risk to the patients who were scanned with the same instruments for imagine as the other infected patients has hampered the growth of the market tremendously.
With the advancement in the technology the use of modern devices for imaging techniques has helped to boost the market for medical imaging. Medical imaging is mainly required in order to detect the pathological changes and structural deformities in the human body. A huge number of people suffer with traumatic injuries who required the imaging techniques in order to detect the structural deformities and pathological changes in the body. A huge number of people in the world belong to the geriatric population who suffer with multiple chronic diseases which require the imaging techniques in order to decide the prognosis of the disease which helps to select a suitable line of treatment for the patient. Imaging techniques with artificial intelligence have been introduced during the pandemic in order to make a proper judgement regarding the condition of the patient and hence take the necessary steps for the further treatment. Multiple steps have been taken teaching hospitals in order to provide a proper training to the medical staff regarding the advance technology is used which has a significant role to play in the health care sector.
The introduction of artificial intelligence into the imaging techniques has helped to provide better results and the boosted the growth of the market during the forecast period. A number of lucrative offers have been introduced by the key market players in order to increase the demand for imaging techniques among the patients. Attractive reimbursement facilities which have been provided by the insurance companies helps to boost the market to a great extent. The insurance companies are making constant efforts in order to provide the best facilities to the patient you order to encourage them to purchase bigger policies. This is indirectly helping the medical imaging market to record a huge revenue return from the market. The use of the imagine techniques have been made in order to observe the minute changes which are invisible to the human eye. It helps in deciding a proper diagnosis for the condition of the patient which helps to select proper line of treatment for the patient.
The large disposable income which is present with the people in the developed nations has encouraged people to opt for imaging procedures in order to get a proper treatment done. The medical imaging market has also seen a tremendous growth due to the presence of the sports sector which presents a number of injuries which require special imaging techniques in order to provide a quicker and accurate treatment to the patient and restore health faster. Sports medicine makes use of the imagine techniques on a large scale in order to increase its accuracy and precision in treating the patients properly with the best services. These multiple reasons prove to be the growth factors for the market during the forecast period.
Report Coverage | Details |
Market Size in 2023 | USD 47.25 Billion |
Market Size in 2024 | USD 49.61 Billion |
Market Size by 2034 | USD 80.52 Billion |
Growth Rate from 2024 to 2034 | CAGR of 4.96% |
Base Year | 2024 |
Forecast Period | 2024 to 2034 |
Segments Covered | Product, Application, End User, and Region |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
On the basis of product, X ray have dominated the segment as a result of its extensive use by the common people. Any regular injury which takes place is followed by an x-ray imaging process which helps to detect the extent of damage that has taken place and helps the position to decide a suitable line of treatment for the patient. This technology is mostly available even in the rural areas where technology haven't been seen on a large scale.
The ultrasound segment is expected to show the fastest growth as a result of its availability in most of the parts of the world. Beginning from gynecological cases to general abdomen related disorders are followed by and ultrasound imaging which helps to detect the probable causes of the disorder. This segment proves to be the fastest growing market as a result of its extensive use in the health care system in order to detect the smallest changes in the abdomen and pelvis region of the body. The use of magnetic resonance imaging techniques have been seen rapidly in the cases where normal scans did not provide sufficient evidence regarding the disorder presented by the patient. This technology faces some barriers as a result of its high cost which is not easy to bear with for the common people. The other technologies which are used include computer tomography and nuclear imaging which provide accurate results and help in deciding a prognosis of the case.
On the basis of end user, the hospital sector has shown the fastest growth as a result of the availability of multiple facilities within the same limits which helps the patient to take advantage of these facilities without facing any discomfort. It is a primary center where a patient visits after they face any problem with their body. A hospital setup provides a huge variety of facilities and services along with a trained medical staff which proves to be or driving force for this particular segment. A hospital setup is potent enough to provide with facilities of imaging techniques as a result of the huge space available.
A diagnostic imaging center also provides with adequate facilities required for the imaging processes. This segment is also expected to show a great revenue return in the coming years. This facility is mainly made use of by the general clinics and small health care setups who cannot afford to keep these types of machines. The drawback in this segment is that, the availability of various other facilities is absent which proves to be or challenge for the market. The other segments under this category include the portable type of imaging devices which are usually used by the clinics and the small healthcare centers in order to provide multiple services to the patient and thus increase its revenue.
Recent developments
Segments Covered
By Product
By Application
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Imaging Market
5.1. COVID-19 Landscape: Medical Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Imaging Market, By Product
8.1. Medical Imaging Market, by Product, 2024-2034
8.1.1 X-Ray Devices
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Magnetic Resonance Imaging (MRI)
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Ultrasound
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Computed Tomography
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Nuclear Imaging
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Mammography
8.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Medical Imaging Market, By Application
9.1. Medical Imaging Market, by Application, 2024-2034
9.1.1. Obstetrics and Gynecology Health
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Orthopedics and Musculoskeletal
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Neuro and Spine
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Cardiovascular and Thoracic
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. General Imaging
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Oncology
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Urology
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.7. Breast Health
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Medical Imaging Market, By End User
10.1. Medical Imaging Market, by End User, 2024-2034
10.1.1. Diagnostic imaging centers
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Medical Imaging Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Forecast, by End User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End User (2021-2034)
Chapter 12. Company Profiles
12.1. Siemens Healthineers
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Canon Medical Systems Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. GE Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Koninklijke Philips N.V.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Mindray Medical International
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Esaote
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Hologic
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Samsung Medison Co.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. FUJIFILM VisualSonics Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client